AVTR logo

AVANTOR INC

AVTRNYSE
πŸ† #762 by market capEarnings Nov 4US Equity
$361.09β–Ό $26.32 (βˆ’7.29%)
Simulated price
1hβ€”
24hβ–Ό 7.3%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$9.29B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-1.6%
Declining
πŸ“ŠGross Margin
31.8%
Moderate
πŸ’΅FCF Margin
6.9%
Moderate
βš–οΈP/S Ratio
1.4x
Cheap
Otter Score
42
Weak
No chart data available for AVTR.

Trading Snapshot

Day Range
$356.77 – $366.08
52-Week Range
$7.27 – $15.93
Volume
$2.11B
Avg Volume
$2.23B
Shares Outstanding
676.4M
Next Earnings
Oct 19, 2026

Fundamentals Snapshot

Annual Revenue
$6.55B
Last Q Revenue
$1.69B
P/E Ratio
β€”
P/S Ratio
1.4x
EPS (TTM)
$-0.85
Dividend Yield
β€”

Why Investors Own AVTR

  • βœ“High-growth profile β€” revenue up +59.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 28% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$6.55Bβ–² +65.6% YoY
Gross Margin (TTM)
27.8%β–² +1.7% YoY
Operating Income (TTM)
$1.40Bβ–² +65.6% YoY
Free Cash Flow (TTM)
$373Mβ–² +65.6% YoY

About AVANTOR INC

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
42/100

Analyst Price Target

β“˜
Average Target
$372.77
β–² +3.2% Upside
High Target$459.39
Low Target$319.41
Based on 24 analysts

Latest News & Updates